| Product Code: ETC6191014 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Deep | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The single molecule real-time (SMRT) sequencing market in Australia is gaining momentum owing to advances in genomics research, clinical diagnostics, and biotechnology applications. This technology offers high-resolution, long-read DNA sequencing that is particularly beneficial for complex genome analysis. Growth is further supported by increasing funding for precision medicine and the establishment of genomics research institutions across the country.
Australia is observing growing interest in SMRT sequencing owing to the demand for accurate genomic data in clinical diagnostics, agriculture, and cancer research. Technological advancements and reduced sequencing costs are making this method more accessible. Supportive research funding and partnerships with global genomic firms are expanding market penetration.
The Single Molecule Real Time Sequencing (SMRT) market in Australia encounters challenges related to its relatively high cost and technical complexity. The instruments used in SMRT sequencing are expensive, which limits their accessibility, particularly for smaller research institutions or laboratories with limited budgets. Moreover, the technology still faces limitations in terms of scalability and throughput, which makes it less attractive compared to other sequencing methods that are more widely adopted. The complexity of data interpretation also presents a significant challenge, as researchers and clinicians need to develop a deeper understanding of the results, which can delay the adoption of the technology.
Australias expanding biotechnology sector and its commitment to precision medicine create strong investment potential in SMRT sequencing. Investors can target partnerships with research institutes, funding next-gen sequencing startups, or setting up sequencing service hubs for academic and pharmaceutical clients.
The Australian government promotes cutting-edge genomic and sequencing technologies through its National Genomics Policy Framework and grants from the National Health and Medical Research Council (NHMRC). Investments in genomic medicine as part of the Medicare Benefits Schedule (MBS) are expanding, and the government supports public-private partnerships to increase research infrastructure like sequencing platforms including SMRT technologies.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Single-Molecule Real-Time Sequencing Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Single-Molecule Real-Time Sequencing Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Single-Molecule Real-Time Sequencing Market - Industry Life Cycle |
3.4 Australia Single-Molecule Real-Time Sequencing Market - Porter's Five Forces |
3.5 Australia Single-Molecule Real-Time Sequencing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 Australia Single-Molecule Real-Time Sequencing Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.7 Australia Single-Molecule Real-Time Sequencing Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
4 Australia Single-Molecule Real-Time Sequencing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for personalized medicine and precision healthcare |
4.2.2 Technological advancements in single-molecule real-time sequencing |
4.2.3 Growing research and development activities in genomics and molecular biology |
4.3 Market Restraints |
4.3.1 High cost associated with single-molecule real-time sequencing technology |
4.3.2 Limited awareness and adoption of the technology in the market |
5 Australia Single-Molecule Real-Time Sequencing Market Trends |
6 Australia Single-Molecule Real-Time Sequencing Market, By Types |
6.1 Australia Single-Molecule Real-Time Sequencing Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Australia Single-Molecule Real-Time Sequencing Market Revenues & Volume, By Application, 2021- 2031F |
6.1.3 Australia Single-Molecule Real-Time Sequencing Market Revenues & Volume, By DNA Sequencing, 2021- 2031F |
6.1.4 Australia Single-Molecule Real-Time Sequencing Market Revenues & Volume, By RNA Sequencing, 2021- 2031F |
6.1.5 Australia Single-Molecule Real-Time Sequencing Market Revenues & Volume, By Epigenetics, 2021- 2031F |
6.1.6 Australia Single-Molecule Real-Time Sequencing Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F |
6.1.7 Australia Single-Molecule Real-Time Sequencing Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Australia Single-Molecule Real-Time Sequencing Market, By Product |
6.2.1 Overview and Analysis |
6.2.2 Australia Single-Molecule Real-Time Sequencing Market Revenues & Volume, By Consumable, 2021- 2031F |
6.2.3 Australia Single-Molecule Real-Time Sequencing Market Revenues & Volume, By Instrument, 2021- 2031F |
6.2.4 Australia Single-Molecule Real-Time Sequencing Market Revenues & Volume, By Services, 2021- 2031F |
6.3 Australia Single-Molecule Real-Time Sequencing Market, By End-Users |
6.3.1 Overview and Analysis |
6.3.2 Australia Single-Molecule Real-Time Sequencing Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Australia Single-Molecule Real-Time Sequencing Market Revenues & Volume, By Diagnostic Laboratories, 2021- 2031F |
6.3.4 Australia Single-Molecule Real-Time Sequencing Market Revenues & Volume, By Biopharmaceutical Companies, 2021- 2031F |
6.3.5 Australia Single-Molecule Real-Time Sequencing Market Revenues & Volume, By Academic Institutes and Research Centers, 2021- 2031F |
6.3.6 Australia Single-Molecule Real-Time Sequencing Market Revenues & Volume, By Others, 2021- 2031F |
7 Australia Single-Molecule Real-Time Sequencing Market Import-Export Trade Statistics |
7.1 Australia Single-Molecule Real-Time Sequencing Market Export to Major Countries |
7.2 Australia Single-Molecule Real-Time Sequencing Market Imports from Major Countries |
8 Australia Single-Molecule Real-Time Sequencing Market Key Performance Indicators |
8.1 Adoption rate of single-molecule real-time sequencing technology in research institutions and healthcare facilities |
8.2 Number of research publications utilizing single-molecule real-time sequencing technology |
8.3 Investment trends in companies involved in developing and commercializing single-molecule real-time sequencing platforms |
8.4 Number of collaborations and partnerships between key industry players and research institutions for advancing the technology |
8.5 Rate of improvement in sequencing accuracy and efficiency of single-molecule real-time sequencing platforms |
9 Australia Single-Molecule Real-Time Sequencing Market - Opportunity Assessment |
9.1 Australia Single-Molecule Real-Time Sequencing Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 Australia Single-Molecule Real-Time Sequencing Market Opportunity Assessment, By Product, 2021 & 2031F |
9.3 Australia Single-Molecule Real-Time Sequencing Market Opportunity Assessment, By End-Users, 2021 & 2031F |
10 Australia Single-Molecule Real-Time Sequencing Market - Competitive Landscape |
10.1 Australia Single-Molecule Real-Time Sequencing Market Revenue Share, By Companies, 2024 |
10.2 Australia Single-Molecule Real-Time Sequencing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here